Armstrong-James D - Search Results

1

Update on the treatment of chronic pulmonary aspergillosis.

Armstrong-James D, Kosmidis C, Bromley M. Armstrong-James D, et al. Curr Opin Infect Dis. 2023 Apr 1;36(2):146-151. doi: 10.1097/QCO.0000000000000913. Curr Opin Infect Dis. 2023. PMID: 36912585 Review.

2

Impaired interferon-gamma responses, increased interleukin-17 expression, and a tumor necrosis factor-alpha transcriptional program in invasive aspergillosis.

Armstrong-James DP, Turnbull SA, Teo I, Stark J, Rogers NJ, Rogers TR, Bignell E, Haynes K. Armstrong-James DP, et al. J Infect Dis. 2009 Oct 15;200(8):1341-51. doi: 10.1086/605931. J Infect Dis. 2009. PMID: 19754306

3

Immunotherapy for fungal infections.

Armstrong-James D, Harrison TS. Armstrong-James D, et al. Curr Opin Microbiol. 2012 Aug;15(4):434-9. doi: 10.1016/j.mib.2012.06.001. Epub 2012 Aug 10. Curr Opin Microbiol. 2012. PMID: 22884572 Review.

4

The pH-responsive PacC transcription factor of Aspergillus fumigatus governs epithelial entry and tissue invasion during pulmonary aspergillosis.

Bertuzzi M, Schrettl M, Alcazar-Fuoli L, Cairns TC, Muñoz A, Walker LA, Herbst S, Safari M, Cheverton AM, Chen D, Liu H, Saijo S, Fedorova ND, Armstrong-James D, Munro CA, Read ND, Filler SG, Espeso EA, Nierman WC, Haas H, Bignell EM. Bertuzzi M, et al. PLoS Pathog. 2014 Oct 16;10(10):e1004413. doi: 10.1371/journal.ppat.1004413. eCollection 2014 Oct. PLoS Pathog. 2014. PMID: 25329394 Free PMC article.

5

The serum opsonin L-ficolin is detected in lungs of human transplant recipients following fungal infections and modulates inflammation and killing of Aspergillus fumigatus.

Bidula S, Sexton DW, Abdolrasouli A, Shah A, Reed A, Armstrong-James D, Schelenz S. Bidula S, et al. J Infect Dis. 2015 Jul 15;212(2):234-46. doi: 10.1093/infdis/jiv027. Epub 2015 Jan 22. J Infect Dis. 2015. PMID: 25612732

6

Nebulised amphotericin B-polymethacrylic acid nanoparticle prophylaxis prevents invasive aspergillosis.

Shirkhani K, Teo I, Armstrong-James D, Shaunak S. Shirkhani K, et al. Nanomedicine. 2015 Jul;11(5):1217-26. doi: 10.1016/j.nano.2015.02.012. Epub 2015 Mar 16. Nanomedicine. 2015. PMID: 25791815 Free PMC article.

7

Caspofungin Increases Fungal Chitin and Eosinophil and γδ T Cell-Dependent Pathology in Invasive Aspergillosis.

Amarsaikhan N, Sands EM, Shah A, Abdolrasouli A, Reed A, Slaven JE, Armstrong-James D, Templeton SP. Amarsaikhan N, et al. J Immunol. 2017 Jul 15;199(2):624-632. doi: 10.4049/jimmunol.1700078. Epub 2017 May 31. J Immunol. 2017. PMID: 28566368 Free PMC article.

8

Immunotherapeutic approaches to treatment of fungal diseases.

Armstrong-James D, Brown GD, Netea MG, Zelante T, Gresnigt MS, van de Veerdonk FL, Levitz SM. Armstrong-James D, et al. Lancet Infect Dis. 2017 Dec;17(12):e393-e402. doi: 10.1016/S1473-3099(17)30442-5. Epub 2017 Jul 31. Lancet Infect Dis. 2017. PMID: 28774700 Free article. Review.

9

Posaconazole for the treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.

Periselneris J, Nwankwo L, Schelenz S, Shah A, Armstrong-James D. Periselneris J, et al. J Antimicrob Chemother. 2019 Jun 1;74(6):1701-1703. doi: 10.1093/jac/dkz075. J Antimicrob Chemother. 2019. PMID: 30805605 Free PMC article.

10

Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis.

Armstrong-James D, Youngs J, Bicanic T, Abdolrasouli A, Denning DW, Johnson E, Mehra V, Pagliuca T, Patel B, Rhodes J, Schelenz S, Shah A, van de Veerdonk FL, Verweij PE, White PL, Fisher MC. Armstrong-James D, et al. Eur Respir J. 2020 Oct 1;56(4):2002554. doi: 10.1183/13993003.02554-2020. Print 2020 Oct. Eur Respir J. 2020. PMID: 32703771 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

105 results

Search Page